AUROBINDO PHARMA LTD.
BSE: 524804
Revenue & Profit Trend
in croresMargin Trend
percentage| Period | Q1 FY27 | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 2.8K+0.5% | 2.8K+1.4% | 2.7K-1.5% | 2.8K-2.1% | 2.8K+4.3% | 2.7K-6.3% | 2.9K+3.3% | 2.8K |
| Other Income | 241.89+13.0% | 214.09+64.5% | 130.15-18.4% | 159.52+90.4% | 83.77-26.5% | 113.98+110.1% | 54.26-55.8% | 122.66 |
| Total Income | 3.0K+1.4% | 3.0K+4.3% | 2.9K-2.4% | 2.9K+0.6% | 2.9K+3.0% | 2.8K-4.2% | 3.0K+0.8% | 2.9K |
| EXPENSES | ||||||||
| Expenditure | 2.0K-4.3% | 2.1K+2.2% | 2.1K-5.3% | 2.2K+0.6% | 2.2K-4.7% | 2.3K-2.0% | 2.3K+5.1% | 2.2K |
| Tax | 270.86+47.1% | 184.08-7.9% | 199.83+14.9% | 173.91-8.9% | 190.96+29.6% | 147.35-8.4% | 160.89-13.6% | 186.22 |
| PROFIT | ||||||||
| PBT | 1.0K+15.0% | 876.31+12.1% | 781.90+3.5% | 755.28+0.7% | 750.09+35.0% | 555.52-12.2% | 632.94-12.5% | 723.75 |
| Net Profit | 737.22+6.5% | 692.23+18.9% | 582.07+0.1% | 581.37+4.0% | 559.13+37.0% | 408.17-13.5% | 472.05-12.2% | 537.53 |
| KEY METRICS | ||||||||
| OPM % | 31.51%+3.47pp | 28.04%-0.06pp | 28.10%+2.12pp | 25.98%-1.98pp | 27.96%+6.13pp | 21.83%+6.60pp | 15.23%-1.81pp | 17.04% |
| NPM % | 24.24%+1.17pp | 23.07%+2.84pp | 20.23%+0.52pp | 19.71%+0.64pp | 19.07%+4.73pp | 14.34%-1.55pp | 15.89%-2.35pp | 18.24% |
| EPS | 12.75+7.0% | 11.92+19.0% | 10.02+0.1% | 10.01+3.9% | 9.63+37.0% | 7.03-13.5% | 8.13-11.7% | 9.21 |
Corporate Events
Board Meeting
The 39th Annual General Meeting of Aurobindo Pharma Limited …
BSE Filing ↗Board Meeting
A Meeting of the Board of Directors of the Company will be h…
BSE Filing ↗Board Meeting
The Board of Directors of Apitoria Pharma Private Limited, a…
BSE Filing ↗Board Meeting
The Board of Directors considered and approved the re-appoin…
BSE Filing ↗Board Meeting
To consider and approve a proposal for buyback of the fully …
BSE Filing ↗Board Meeting
Standalone & Consolidated Unaudited Financial Results of the…
BSE Filing ↗Board Meeting
Consider and approve Intimation of Board meeting, Standalone…
BSE Filing ↗Board Meeting
consider and approve Intimation of Board Meeting, consider a…
BSE Filing ↗Board Meeting
Consider and approve Intimation of Board meeting, Standalone…
BSE Filing ↗Board Meeting
buyback of the fully paid-up equity shares of the Company
BSE Filing ↗Board Meeting
Consideration and approval of Standalone & Consolidated Audi…
BSE Filing ↗Board Meeting
Consideration and approval of unaudited standalone and conso…
BSE Filing ↗Board Meeting
Standalone & Consolidated Unaudited Financial Results for th…
BSE Filing ↗Board Meeting
To consider and approve the Standalone & Consolidated Unaudi…
BSE Filing ↗